Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Share-based Compensation (2019 - 2022)

Inventiva (IVEVF) posted Share-based Compensation of $1.7 million for Q4 2022, up 166.66% on a QoQ basis from -$2.5 million in Q3 2022, and up 61.2% year-over-year from $1.0 million in Q4 2021.

Analysis

Inventiva (IVEVF) Share-based Compensation (2019 - 2022) Analysis & Trends

Inventiva has reported Share-based Compensation for 4 years, with the latest figure at $1.7 million in Q4 2022.

  • On a quarterly basis, Share-based Compensation rose 61.2% year-over-year to $1.7 million in Q4 2022; TTM through Dec 2022 was $1.3 million, a 66.2% decrease from a year earlier, with the FY2025 full-year figure at $31.2 million, up 714.53% from the prior year.
  • Share-based Compensation was $1.7 million for Q4 2022 at Inventiva, up from -$2.5 million in the prior quarter.
  • The five-year high for Share-based Compensation was $1.7 million in Q4 2022, with the low at -$2.5 million in Q3 2022.
  • Average Share-based Compensation over 4 years is $631676.0, with a median of $1.1 million recorded in 2021.
  • The sharpest annual moves came in 2021 and 2022: Share-based Compensation plunged 92.75% in 2021, then soared 61.2% in 2022.
  • Over 4 years, Share-based Compensation stood at $1.2 million in 2019, then surged by 33.84% to $1.6 million in 2020, then sank by 36.71% to $1.0 million in 2021, then jumped by 61.2% to $1.7 million in 2022.
  • The last three Share-based Compensation figures came in at $1.7 million (Q4 2022), -$2.5 million (Q3 2022), and $1.0 million (Q4 2021), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Johnson & Johnson 646.71 Bn 625.95 Bn 17.26 Bn -950.00 Mn
2 AbbVie 442.22 Bn 435.65 Bn 12.70 Bn 166.00 Mn
3 Merck 366.92 Bn 359.78 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 266.90 Bn 259.21 Bn 11.24 Bn -
5 Pfizer 159.20 Bn 147.50 Bn 10.94 Bn 249.00 Mn
6 Sanofi 52.44 Bn 45.06 Bn 10.79 Bn -
7 Revolution Medicines 44.11 Bn 44.11 Bn - 277.20 Mn
8 Incyte 25.38 Bn 20.85 Bn 1.57 Bn 67.26 Mn
9 United Therapeutics 21.50 Bn 18.84 Bn 683.80 Mn 19.00 Mn
10 Inventiva 693.72 Mn 693.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.68 Mn
Sep 22, 2022 -2.51 Mn
Dec 31, 2021 1.04 Mn
Jun 30, 2021 1.08 Mn
Mar 31, 2021 19,299.78
Dec 31, 2020 1.64 Mn
Jun 30, 2020 1.25 Mn
Mar 31, 2020 266,049.31
Dec 31, 2019 1.23 Mn